ジェノタイピング市場- 世界の産業規模、シェア、動向、機会、予測、製品別、技術別、用途別、最終用途別、地域別セグメント、地域別、競合、2020年～2030年

ジェノタイピングの世界市場規模は2024年に162億5,000万米ドルで、予測期間中のCAGRは8.74%で2030年には268億7,000万米ドルに達すると予測されています。

世界のジェノタイピング市場は、バイオテクノロジーとライフサイエンスの分野でダイナミックかつ急速に成長している分野です。ジェノタイピングは、DNA配列の変異を含む個人の遺伝子構成を決定するプロセスです。この情報は、個別化医療や疾病研究から農業や家系検査に至るまで、幅広い用途において極めて重要です。

ジェノタイピング市場は、特にゲノム研究に対する政府機関からの資金提供の増加や、研究の迅速化を目的とした製薬企業やバイオテクノロジー企業からの拠出によって成長が見込まれています。その顕著な例として、米国国立衛生研究所（NIH）が2018年9月、精密医療研究に特化した米国全土の3つのゲノムセンター設立のための「All of Us Research Program」に2,860万米ドルを供与したことが挙げられます。

がんや遺伝性疾患を含む慢性疾患の世界の増加は、遺伝子型に基づく診断検査の需要を促進すると考えられています。例を挙げると、世界保健機関（WHO）は、2020年に世界で1,910万人が新たにがんと診断されると報告しています。さらに、ヒト乳頭腫ウイルス（HPV）やB型肝炎ウイルス（HBV）／C型肝炎ウイルス（HCV）のようながんを引き起こすウイルスは、世界規模でがん関連死の約20％を引き起こしています。がん患者数は、人口増加と高齢化により、今後20年間で約70％増加すると予測されています。したがって、がんの有病率の増加は、この市場の重要な原動力になると予想されます。

主な市場促進要因

ジェノタイピング技術の進歩

主な市場課題

データ管理と解釈

主要市場動向

マルチオミクスアプローチの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のジェノタイピング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（機器、試薬・キット、ソフトウェア、サービス）
  • 技術別（PCR、キャピラリー電気泳動、マイクロアレイ、シーケンシング、質量分析、その他）
  • 用途別（薬理ゲノム学、診断および個別化医療、農業バイオテクノロジー、動物遺伝学、その他）
  • 最終用途別（製薬・バイオ医薬品企業、診断・調査機関、学術機関、その他）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • 製品別
  • 技術別
  • 用途別
  • 最終用途別
  • 地域別

第6章 北米のジェノタイピング市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のジェノタイピング市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域のジェノタイピング市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米のジェノタイピング市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのジェノタイピング市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific Inc.
• Illumina Inc.
• QIAGEN N.V.
• F Hoffmann-La Roche AG
• Danaher Corporation
• Agilent Technologies, Inc.
• Eurofins Scientific Inc.
• GE HealthCare
• Bio-Rad Laboratories Inc.
• Standard BioTools（TM）

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Genotyping Market was valued at USD 16.25 billion in 2024 and is expected to reach USD 26.87 billion by 2030 with a CAGR of 8.74% during the forecast period. The global genotyping market is a dynamic and rapidly growing sector within the field of biotechnology and life sciences. Genotyping is the process of determining an individual's genetic makeup, including variations in their DNA sequence. This information is crucial for a wide range of applications, from personalized medicine and disease research to agriculture and ancestry testing.

The genotyping market is expected to experience growth driven by increased government funding, particularly for genomic research from governmental bodies, as well as contributions from pharmaceutical and biotechnology companies, aimed at expediting research. A noteworthy example of this is the National Institutes of Health (NIH) granting USD 28.6 million in September 2018 to the "All of Us Research Program" for establishing three genome centers across the United States dedicated to precision medicine research.

The global rise in chronic diseases, including cancer and genetic disorders, is set to fuel the demand for genotypic-based diagnostic testing. To illustrate, the World Health Organization (WHO) reported 19.1 million new cancer cases diagnosed worldwide in 2020. Moreover, cancer-causing viruses like Human Papilloma Virus (HPV) and Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) are responsible for approximately 20% of cancer-related deaths on a global scale. The number of cancer cases is projected to increase by roughly 70% over the next two decades, driven by population growth and aging. Therefore, the increasing prevalence of cancer is expected to be a significant driving force for this market.

Key Market Drivers

Advancements in Genotyping Technologies

Genotyping, the process of analyzing an individual's genetic makeup, is undergoing a revolution thanks to advancements in genotyping technologies. These innovations have not only enhanced the efficiency and accuracy of genotyping but also expanded its applications across various sectors, including healthcare, research, agriculture, and personalized medicine. One of the most significant factors propelling the genotyping market forward is the advent of high-throughput genotyping platforms. These platforms can analyze thousands or even millions of genetic markers in a single experiment, significantly increasing the speed and cost-effectiveness of genotyping. Researchers and clinicians can process larger datasets quickly, making genotyping accessible for a wide range of applications.

Next-generation sequencing, or NGS, is a game-changer in genotyping. It allows for the simultaneous sequencing of a person's entire genome, making it possible to identify even the rarest genetic variations. NGS is not only faster and more affordable than traditional Sanger sequencing, but it also generates vast amounts of data, enabling comprehensive genomic analysis. This technology has become essential in research, clinical diagnostics, and personalized medicine. Advancements in genotyping technologies have significantly improved the accuracy and resolution of genotyping results. Single nucleotide polymorphism (SNP) genotyping, for example, has become highly accurate, making it an invaluable tool in identifying genetic markers associated with diseases, drug responses, and other traits. This precision has bolstered the credibility of genotyping in both research and clinical applications.

Key Market Challenges

Data Management and Interpretation

One of the primary challenges in the genotyping market is the management and interpretation of the massive amounts of genetic data generated. Genotyping technologies, especially high-throughput platforms and next-generation sequencing, produce enormous datasets. The efficient analysis and interpretation of this data requires robust bioinformatics tools and skilled personnel, making data management a significant hurdle.

Key Market Trends

Integration of Multi-Omics Approaches

Genotyping is increasingly being integrated with other omics technologies such as proteomics and metabolomics. This holistic approach allows researchers to gain a more comprehensive understanding of biological systems. By analyzing genetic, protein, and metabolic data together, researchers can uncover intricate relationships and potential biomarkers for various diseases and conditions.

Key Market Players

• Thermo Fisher Scientific Inc.
• Illumina Inc.
• QIAGEN N.V.
• F Hoffmann-La Roche AG
• Danaher Corporation
• Agilent Technologies, Inc.
• Eurofins Scientific Inc.
• GE HealthCare
• Bio-Rad Laboratories Inc.
• Standard BioTools(TM)

Report Scope:

In this report, the Global Genotyping Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genotyping Market, By Product:

• Instruments
• Reagents & Kits
• Software and Services

Genotyping Market, By Technology:

• PCR
• Capillary Electrophoresis
• Microarrays
• Sequencing
• Mass Spectrometry
• Others

Genotyping Market, By Application:

• Pharmacogenomics
• Diagnostics and Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others

Genotyping Market, By End Use:

• Pharmaceutical and Biopharmaceutical Companies
• Diagnostics and Research Laboratories
• Academic Institutes
• Others

Genotyping Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Genotyping Market.

Available Customizations:

Global Genotyping market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genotyping Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
  • 5.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
  • 5.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
  • 5.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product
  • 5.3.2. By Technology
  • 5.3.3. By Application
  • 5.3.4. By End Use
  • 5.3.5. By Region

6. North America Genotyping Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
  • 6.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
  • 6.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
  • 6.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Genotyping Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Genotyping Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Genotyping Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe Genotyping Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
  • 7.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
  • 7.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
  • 7.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Genotyping Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. United Kingdom Genotyping Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. France Genotyping Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Genotyping Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Genotyping Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia-Pacific Genotyping Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
  • 8.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
  • 8.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
  • 8.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Genotyping Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. Japan Genotyping Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. India Genotyping Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. Australia Genotyping Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. South Korea Genotyping Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. South America Genotyping Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
  • 9.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
  • 9.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
  • 9.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Genotyping Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina Genotyping Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia Genotyping Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. Middle East and Africa Genotyping Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
  • 10.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
  • 10.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
  • 10.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Genotyping Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia Genotyping Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE Genotyping Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use
  • 10.3.4. Kuwait Genotyping Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product
      • 10.3.4.2.2. By Technology
      • 10.3.4.2.3. By Application
      • 10.3.4.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Illumina Inc.
• 14.3. QIAGEN N.V.
• 14.4. F Hoffmann-La Roche AG
• 14.5. Danaher Corporation
• 14.6. Agilent Technologies, Inc.
• 14.7. Eurofins Scientific Inc.
• 14.8. GE HealthCare
• 14.9. Bio-Rad Laboratories Inc.
• 14.10. Standard BioTools(TM)

15. Strategic Recommendations

16. About Us & Disclaimer